Intellia Therapeutics Inc. (NTLA) Gained 5.34% or 1.12 To Price $22.08 On Wednesday


Intellia Therapeutics Inc. (NTLA) gained 5.34% or 1.12 to $22.08. It is near 913235 shares traded, which is 62.2% compare to the average total volume 1.47 million. The market cap of NTLA is $935.91 million. The year to date change is -2.56%. The 52 week price range is from $11.15 to $35.99. Price of NTLA have changed -3.85% during last week. It have changed -25.04% over last month, -4.81% over last 3 months, -29.48% over last 6 months and 39.64% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NTLA is 25.41. It is 15.08% above current price. The 200-day Moving Averages for NTLA is 21.69. It is -1.77% below current price. The 52-week High is 35.99. It is 63.00% from the current price. The 52-week Low is 11.15. It is -49.50% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NTLA is 2.75 on 2018-03-15. Short % to float is 9.70%. There are some statistics of NTLA. It is has market cap $935.91 million. The share outstanding is 42.39 million. The average volume is 1.47 million. The revenue is 19.45M. The percent of top 15 Institution holding is 86.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NTLA is -26.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NTLA is -20.01%.


Tags:

Share this post